Loading...

Epigenetic Diagnostics And NETs Platform Will Reshape Long Term Prospects In Cancer And Autoimmune Care

Published
19 Dec 25
Views
2
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-62.1%
7D
-4.8%

Author's Valuation

US$391.5% undervalued intrinsic discount

AnalystHighTarget Fair Value